Price $120.00 |
Market Cap
212.3B
|
Sector Health Care |
Div. Growth
12.50%
|
|
P/E
47.3
|
P/B
6.44
|
P/S
6.1
|
Dividend %
1.50%
|
|
P/CF
71.5
|
P/FCF
67.3
|
Op. Cash Flow
7.9M
|
FCF
1.7
|
|
Op. Margin
15.80%
|
Net Margin
13.00%
|
ROE
14.40%
|
ROI
9.70%
|
|
ROA
6.50%
|
EPS Growth
21.50%
|
Current Ratio
1.7
|
Debt/Equity
56.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Amneal Pharmaceuticals Inc (AMRX) | $5.67 | - | - | 2.02B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
| RadNet Inc. (RDNT) | $22.11 | - | - | 1.14B | Strong Buy |
| Regulus Therapeutics Inc (RGLS) | $1.23 | - | - | 113.1M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.97 | - | - | 45.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
